natriuretic

(redirected from Natriuretic peptides)
Also found in: Dictionary, Medical.

natriuretic

[¦nā·trē·yu̇′red·ik]
(pharmacology)
A medicinal agent which inhibits reabsorption of cations, particularly sodium, from urine.
References in periodicals archive ?
PL-3994 is a synthetic natriuretic peptide receptor-A agonist developed by Palatin for treatment of heart failure and other indications.
In this prospective study we found an independent association between the risk of recurrent CVD events and concentrations of MR-proANP and NT-proBNP when each of these natriuretic peptides was used as a single variable in different models after adjustment for various established cardiovascular risk factors.
Brain natriuretic peptide is a polypeptide consisting of 32 amino acids and a hormone released from the ventricles of the heart in case of hemodynamic stress and congestive heart failure Turkish Archives of Pediatrics, published by Galenos Publishing (4-6).
This study emphasized that echocardiography and the amino-terminal pro-B-type natriuretic peptides (NT-proBNP) provide powerful incremental assessment of LV function.
Nile is initially focusing its efforts on developing its lead compound, cenderitide, a novel, rationally designed chimeric peptide for the treatment of heart failure, and CU-NP, a second novel, rationally designed natriuretic peptide.
The impact of cardiac natriuretic peptide determination on the diagnosis and management of heart failure.
B-type natriuretic peptides and their relation to cardiovascular structure and function in a population-based sample of subjects aged 70 years.
Prognostic value of B-type natriuretic peptides in patients with stable coronary artery disease, the PEACE trial.
Cohort study of plasma natriuretic peptides for identifying left ventricular systolic dysfunction in primary care.
Laboratory testing for natriuretic peptides (including B-type natriuretic peptide [BNP] and its amino-terminal cleavage equivalent, N-terminal fragment [NT-proBNP]) has been shown to be useful for assisting in the diagnostic and prognostic assessment of patients with suspected or confirmed acute decompensated heart failure (ADHF).
Serum levels of natriuretic peptides may be elevated in patients with acute MI, candidates for renal dialysis, or people who have undergone renal dialysis.